Nail psoriasis represents a specific clinical situation within psoriatic disease. Off-label topical therapy is the documented first-line treatment strategy for this localised presentation, with evidence supporting both monotherapy and combination approaches applied directly to the affected nails.
DOI: 10.1016/j.jaad.2019.08.049
The off-label use of topical tazarotene may be recommended as monotherapy or in combination with topical corticosteroids for the treatment of localized pediatric skin or nail psoriasis.
Daily application of tazarotene 0.05% gel to the nails for 8 weeks afforded improvement of the nail disease, but local irritation occurred.
View source ↗